KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,768,000 | -13.8% | 1,400,000 | 0.0% | 1.49% | -10.4% |
| Q2 2023 | $14,812,000 | +0.5% | 1,400,000 | +16.2% | 1.66% | -25.8% |
| Q1 2023 | $14,736,636 | +107908.2% | 1,204,958 | +9.6% | 2.24% | +9.1% |
| Q4 2022 | $13,644 | -99.9% | 1,099,407 | +22.2% | 2.06% | +4.0% |
| Q3 2022 | $12,286,000 | -63.3% | 899,407 | -50.8% | 1.98% | -72.1% |
| Q2 2022 | $33,480,000 | +168.1% | 1,826,491 | +135.2% | 7.08% | +153.8% |
| Q1 2022 | $12,486,000 | -33.3% | 776,514 | -22.3% | 2.79% | -43.5% |
| Q3 2021 | $18,719,000 | +44.5% | 999,433 | +60.8% | 4.94% | +9.3% |
| Q2 2021 | $12,958,000 | -12.1% | 621,493 | +19.2% | 4.52% | -23.1% |
| Q1 2021 | $14,744,000 | +238.2% | 521,555 | +290.7% | 5.87% | +147.8% |
| Q4 2020 | $4,360,000 | – | 133,503 | – | 2.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,807,982 | $59,049,000 | 6.41% |
| ACUTA CAPITAL PARTNERS, LLC | 637,500 | $20,821,000 | 5.67% |
| Asymmetry Capital Management, L.P. | 346,518 | $11,317,000 | 5.16% |
| Affinity Asset Advisors, LLC | 260,000 | $8,492,000 | 4.50% |
| EcoR1 Capital, LLC | 1,773,037 | $57,907,000 | 3.11% |
| VR Adviser, LLC | 575,000 | $18,780,000 | 2.76% |
| COMMODORE CAPITAL LP | 133,503 | $4,360,000 | 2.37% |
| Ghost Tree Capital, LLC | 325,000 | $10,615,000 | 2.36% |
| Avoro Capital Advisors LLC | 4,000,000 | $130,640,000 | 2.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 90,000 | $2,939,000 | 1.71% |